Showing 21-30 of 822 results for "".
About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/movement-disorders/about-the-cover-artist-3/31568/Patrick J. Murphy considered his Parkinson’s disease diagnosis a wake-up call and permission slip to pursue a lifelong dream in fine art.About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/headache-pain/about-the-cover-artist-1/31529/Focused on finding life’s gifts, Emily J. Shapiro’s artwork captures the joy in life and nature she insists on, despite living with migraine.- Can We Boost The Efficacy of Dopaminergic Therapy?https://practicalneurology.com/columns/practice-management/can-we-boost-the-efficacy-of-dopaminergic-therapy/31220/Parkinson’s disease (PD) management continues to prioritize maintaining patients' quality of life and motor function, aligning with the foundational goals established since Dr. James Parkinson’s initial descriptions in 1817. Contemporary treatment primarily focuses on dopamine replacement to counter
Update on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/31283/Stewart J. Tepper, MD, Vice President of the New England Institute for Neurology and Headache, Peter McAllister, MD, FAAN, Chief Medical Officer of the New England Institute for Neurology and Headache, and Teshamae Monteith, MD, Associate Professor and Chief of the Headache Division of the Departmen- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31184/Integrating Antidepressant Therapy in Parkinson’s Disease ManagementDepression is a common comorbidity in Parkinson’s disease (PD) patients, necessitating careful consideration for antidepressant therapy. Dr. Eric J. Ahlskog, a leading neurologist at the Mayo Clinic, emphasizes the interplay between
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31129/Pharmacological Management of Myasthenia Gravis in Young Adults Versus Older PatientsManaging myasthenia gravis (MG) requires tailored pharmacological strategies, especially when comparing young adults to older individuals with similar disease severity. Experts Dr. Henry J. Kaminski and Dr. Zohar Ar
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31314/Persistent Cognitive Deficits Post-Motor Vehicle Accident: A Case Study and Insights on Malingering in Neurological PracticeA 35-year-old male, Mr. M., presented five months after sustaining a whiplash injury from a motor vehicle accident. Initially treated by his chiropractor, Dr. J., Mr. M. contin
MS Minute: Ibudilast
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-ibudilast/31622/Ibudilast is a phosphodiesterase inhibitor that has shown some benefit for progressive multiple sclerosis in a phase 2 trial.Case Report: Occult Spinal Dural Arteriovenous Malformation
https://practicalneurology.com/diseases-diagnoses/stroke/case-report-occult-spinal-dural-arteriovenous-malformation/31947/Paraplegia and a longitudinally extensive spinal lesion were caused by a spinal dural arteriovenous fistula fed bilaterally by the iliolumbar arteries.Dementia Insights: Avoiding Burnout in Dementia Care
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-avoiding-burnout-in-dementia-care/31967/When validation is provided mindfully, greater engagement and satisfaction and less burnout may occur.